Alaunos Therapeutics to Participate in Upcoming Investor Conferences in April
30 March 2023 - 8:30AM
Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq:
TCRT), a leading T-cell receptor (TCR) cell therapy company
advancing a clinical-stage pipeline of therapeutics for solid
tumors, today announced that company management will be
participating in the following upcoming investor conferences.
Cantor's The Future of Oncology Virtual
SymposiumDate: Tuesday, April 4, 2023 Format: Fireside
Chat and 1x1 MeetingsLocation: Virtual
22nd Annual Needham Virtual Healthcare
ConferenceDate: Monday, April 17, 2023Format: Company
Presentation and 1x1 Meetings Location: Virtual
A live webcast of the Needham presentation will
be accessible on the Company’s website in the Investors section
under Events & Presentations at www.alaunos.com. A replay of
the webcast will be available on the Alaunos website for
approximately 90 days following the presentation.
About Alaunos
TherapeuticsAlaunos Therapeutics is a leader in the
science of T-cell receptor cell therapy working to revolutionize
solid cancer treatment and outcomes. The clinical-stage company’s
TCR T-cell therapy (TCR-T) is one of the most advanced TCR programs
targeting driver mutations in solid tumors with an ongoing Phase
1/2 trial of its TCR-T product candidates across six solid cancers.
Alaunos is powered by two proprietary platforms: its elegantly
efficient non-viral Sleeping Beauty cell engineering
platform; and its hunTR® discovery platform, which is
expanding its industry-leading library of TCRs against
high-frequency driver mutations. Alaunos is a part of an ongoing
collaboration with the National Cancer Institute (NCI), part of the
National Institutes of Health (NIH), working to advance the science
of TCR therapy. For more information,
visit www.alaunos.com.
Investor Relations Contact:Alex
LoboStern Investor Relationsalex.lobo@sternir.com
Media Contact:Heather Anderson6
Degrees PRhanderson@6degreespr.com
Alaunos Therapeutics (NASDAQ:TCRT)
Historical Stock Chart
From Apr 2024 to May 2024
Alaunos Therapeutics (NASDAQ:TCRT)
Historical Stock Chart
From May 2023 to May 2024